Factors Associated with Readmission within 30 Days of Hospital Discharge of Psychiatric Patients: Case-Control Study.

IF 1 4区 医学 Q4 NEUROSCIENCES
Héctor Cabello-Rangel, Miriam Estrada-Martínez, Montserrath Martinez-Torres
{"title":"Factors Associated with Readmission within 30 Days of Hospital Discharge of Psychiatric Patients: Case-Control Study.","authors":"Héctor Cabello-Rangel, Miriam Estrada-Martínez, Montserrath Martinez-Torres","doi":"10.62641/aep.v52i4.1651","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Readmission, defined as any admission after discharge from the same hospital, has negative implications for health outcomes. This study aims to identify the sociodemographic and clinical factors associated with hospital readmission among psychiatric patients.</p><p><strong>Methodology: </strong>This case-control study analyzed 202 clinical records of patients admitted to a psychiatric hospital between 2019-2021. The sample was selected using simple random sampling. Qualitative variables were presented using frequencies, percentages, and chi-square tests for association. Quantitative variables were described using central tendency measures and dispersion of data, investigated with the Kolmogorov-Smirnov test, Student's t-test or Wilcoxon test as appropriate. Regression analysis was conducted to determine factors linked to readmission. p < 0.05 was considered.</p><p><strong>Results: </strong>Women accounted for a higher readmission rate (59%). Patients diagnosed with schizophrenia had a higher readmission rate (63%), experienced longer transfer times to the hospital during readmissions, and had shorter hospital stays. Polypharmacy and pharmacological interactions were associated with readmission. Olanzapine treatment was identified as a risk factor for readmission (ExpB = 3.203, 95% CI 1.405-7.306, p = 0.006).</p><p><strong>Conclusions: </strong>The findings suggest avoiding polypharmacy and medications with high side effect profiles to reduce readmissions. This study offers valuable insights for clinical decision-making from admission to discharge planning, aiming to enhance the quality of care.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 4","pages":"405-411"},"PeriodicalIF":1.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11319751/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas espanolas de psiquiatria","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62641/aep.v52i4.1651","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Readmission, defined as any admission after discharge from the same hospital, has negative implications for health outcomes. This study aims to identify the sociodemographic and clinical factors associated with hospital readmission among psychiatric patients.

Methodology: This case-control study analyzed 202 clinical records of patients admitted to a psychiatric hospital between 2019-2021. The sample was selected using simple random sampling. Qualitative variables were presented using frequencies, percentages, and chi-square tests for association. Quantitative variables were described using central tendency measures and dispersion of data, investigated with the Kolmogorov-Smirnov test, Student's t-test or Wilcoxon test as appropriate. Regression analysis was conducted to determine factors linked to readmission. p < 0.05 was considered.

Results: Women accounted for a higher readmission rate (59%). Patients diagnosed with schizophrenia had a higher readmission rate (63%), experienced longer transfer times to the hospital during readmissions, and had shorter hospital stays. Polypharmacy and pharmacological interactions were associated with readmission. Olanzapine treatment was identified as a risk factor for readmission (ExpB = 3.203, 95% CI 1.405-7.306, p = 0.006).

Conclusions: The findings suggest avoiding polypharmacy and medications with high side effect profiles to reduce readmissions. This study offers valuable insights for clinical decision-making from admission to discharge planning, aiming to enhance the quality of care.

精神病患者出院后 30 天内再次入院的相关因素:病例对照研究。
背景:再入院是指从同一家医院出院后的任何一次入院,对健康结果有负面影响。本研究旨在确定与精神病患者再入院相关的社会人口学和临床因素:本病例对照研究分析了 2019-2021 年间入住精神病医院的 202 名患者的临床记录。样本采用简单随机抽样法选出。定性变量采用频率、百分比和相关性的卡方检验。定量变量采用中心倾向测量和数据离散度进行描述,并酌情使用Kolmogorov-Smirnov检验、学生t检验或Wilcoxon检验进行调查。进行回归分析以确定与再入院相关的因素:女性的再入院率较高(59%)。被诊断为精神分裂症的患者再入院率较高(63%),再入院期间转院时间较长,住院时间较短。多重用药和药物相互作用与再入院有关。奥氮平治疗被认为是再入院的风险因素(ExpB = 3.203,95% CI 1.405-7.306,p = 0.006):研究结果表明,避免使用多种药物和副作用大的药物可减少再入院率。这项研究为从入院到出院规划的临床决策提供了宝贵的见解,旨在提高护理质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Actas espanolas de psiquiatria
Actas espanolas de psiquiatria 医学-精神病学
CiteScore
1.70
自引率
6.70%
发文量
46
审稿时长
>12 weeks
期刊介绍: Actas Españolas de Psiquiatría publicará de manera preferente trabajos relacionados con investigación clínica en el área de la Psiquiatría, la Psicología Clínica y la Salud Mental.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信